APA (7th ed.) Citation

SF, F., AJ, N., SA, G., AB, R., JP, C., K, M., . . . JJ, R. (2014). Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: Suspected treatment toxicity. Journal of neuro-oncology, 118(1), 147. https://doi.org/10.1007/s11060-014-1409-2

Chicago Style (17th ed.) Citation

SF, Futterer, Nemeth AJ, Grimm SA, Ragin AB, Chandler JP, Muro K, Marymont MH, and Raizer JJ. "Diffusion Abnormalities of the Corpus Callosum in Patients Receiving Bevacizumab for Malignant Brain Tumors: Suspected Treatment Toxicity." Journal of Neuro-oncology 118, no. 1 (2014): 147. https://doi.org/10.1007/s11060-014-1409-2.

MLA (9th ed.) Citation

SF, Futterer, et al. "Diffusion Abnormalities of the Corpus Callosum in Patients Receiving Bevacizumab for Malignant Brain Tumors: Suspected Treatment Toxicity." Journal of Neuro-oncology, vol. 118, no. 1, 2014, p. 147, https://doi.org/10.1007/s11060-014-1409-2.